Type 2 Diabetes Studies

Study Code: BP27804

Medpace Clinical Pharmacology is conducting an outpatient clinical research trial on an investigational research medication to treat type 2 diabetes in people who are taking only metformin to manage their diabetes.

Eligibility requirements include:

• Diagnosis of type 2 diabetes
• Taking only metformin to manage diabetes
• 18 to 70 years of age
• HgbA1c between 7.0 and 10.5
• Body Mass Index (BMI) of 27 to 42 kg/m² (www.medpacecpu.com has BMI chart)

Study requirements include:

• Available for 20 outpatient visits over a 5 month period
• Stay on current dose of metformin
• Check blood sugars and keep a diary

You will be compensated for time and travel.

Study Code: 1275.1

Medpace Clinical Pharmacology is conducting an outpatient clinical research study to test the safety and effectiveness of an investigational oral medication for Type II Diabetes.

Eligibility requirements include:

• 18 years or older
• Managing your diabetes with Metformin or Diet and Exercise
• HbA_1c (diabetic blood test) in the range of 7.0 to 10.5%

Study requirements include:

• 11 outpatient visits

Benefits include:

• Study-related exams
• Diabetic and nutrition counseling
• Glucose meter and supplies
• Study-related tests, procedures, and physical exams

Reimbursement may be up to $990.00

Take the First Step

Complete the on-line Study Participant Sign-up Form to be included in the database of potential study participants. A recruitment representative will contact you to complete the process. When we have a study for which you may qualify, we will contact you to discuss the details.

Or, call the Medpace Call Center at (513) 366-3222 or (859) 341-9800 between 8:00 AM – 8:00 PM ET, Monday through Friday. One of our recruitment representatives will complete the Medpace Study Participant Sign-up Form with you. Please note that your personal information is kept completely private.

Questions? View our Frequently Asked Questions (FAQ), or call one of our recruitment representatives at (513) 366-3222 or (859) 341-9800 between 8:00 AM – 8:00 PM ET.